Vital Laboratories Private Limited
Aditya Rathi has over a decade of experience in sales and marketing, currently serving in the role of International Sales Marketing at Vital Laboratories Private Limited since January 2020. Prior to this, Aditya worked at Sanofi from January 2017 to December 2020 in a sales capacity, and at The Janssen Pharmaceutical Companies of Johnson & Johnson as a Sales Officer from January 2012 to December 2016. Aditya holds a Master of Business Administration (MBA) from NMIMS Deemed-to-be-University, completed in July 2011, and a Bachelor of Business Administration (BBA) from the same institution, earned in June 2008.
This person is not in any teams
Vital Laboratories Private Limited
1 followers
We, Vital Laboratories Private Limited, are manufactures of pharmaceutical API’s. We started our journey in 1998 with manufacturing Quinine Derivatives and today we are one of the largest manufacturers of Quinine Derivatives globally. We have enlarged our product basket to more than 45 API’S in our product portfolio covering various therapeutic segments. We manufacture various herbal based APIs and synthetic APIs; and market to both Domestic and International Markets. We have a strong portfolio of products having Herbal origin which involves the process of Extraction of the product from medicinal plants. Besides API of herbal origin, we have built up a strong portfolio of Synthetic APIs. Our product portfolio of APIs covering various therapeutic segments like anti-malarial, anti-spasmodic, vitamins, auto-immune, anti-viral, anti- bacterial, muscle relaxants, NSAIDs, etc. Vital is a partner to almost all major pharmaceutical companies in India and has a global reach through its strategic partnerships. Our Company’s strength and its growth is a result of our philosophy to manufacture API right from scratch. Hence ensuring backward integration for most of our products is a key to our success. In the pursuit of our endeavour towards backward integration, through the cultivation in our farms in Australia, we have secured our business of Hyoscine derivatives. Similar integrations in Quinine derivatives and other businesses have strengthened Vital’s position as a reliable partner.